Eli Lilly (LLY) Expands Pipeline with Clazakizumab Agreement, Reuters Reports
According to a Reuters report on February 18, Australia’s CSL said it had granted Eli Lilly and Company (NYSE:LLY) certain rights to develop and commercialize clazakizumab, an anti-interleukin-6 monoclonal...








